Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons

Journal of Neurochemistry

Volumn 106, Issue 4, 2008, Pages 1745-1757

  Kilkus, John P ^b   Goswami, Rajendra ^b   Dawson, Sylvia A ^b   Testai, Fernando D ^b   Berdyshev, Eugeny V ^b   Han, Xianlin ^c   Dawson, Glyn ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Embryonic chick neurons; Fluorescent NBD sphingolipids; Neonatal rat hippocampal neurons; Neonatal rat oligodendrocytes; Neurotumor cell lines; Sphingomyelin synthase

Indexed keywords

CERAMIDE; ENZYME; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN SYNTHASE;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPOLYSIS; MASS SPECTROMETRY; NERVE CELL; NEUROBLASTOMA CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RAT;

4-CHLORO-7-NITROBENZOFURAZAN; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; CERAMIDES; CHICK EMBRYO; CHICKENS; HUMANS; METABOLISM; MICE; NEURONS; OLIGODENDROGLIA; RATS; SPHINGOMYELINS;

RATTUS;

EID: 48749132232     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05490.x     Document Type: Article

References (78)

1. Abe A., Gregory S., Lee L., Killen P. D., Brady R. O., Kulkarni A. Shayman J. A. (2000) Reduction of globotriosylceramide in Fabry disease mice by substrate deprivation. J. Clin. Invest. 105, 1563 1571.
2. Aubin I., Adams C. P., Opsahl S. et al. (2005) A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat. Genet. 37, 803 805.
3. Babia T., Ledesma M. D., Saffrich R., Kok J. W., Dotti C. G. Egea G. (2001) Endocytosis of NBD-sphingolipids in neurons: exclusion from degradative compartments and transport to the Golgi complex. Traffic 2, 395 405.
4. Berdyshev E. V., Gorshkova I. A., Usatyuk P., Zhao Y., Saatian B., Hubbard W. Natarajan V. (2006) De novo biosynthesis of dihydrosphingosine-1- phosphate by sphingosine kinase 1 in mammalian cells. Cell Signal. 18, 1779 1792.
5. Bottenstein J. E. (1986) Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc. Natl Acad. Sci. USA 83, 1955 1959.
6. Brann A. B., Tcherpakov M., Williams I. M., Futerman A. H. Fainzilber M. (2002) Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. 277, 9812 9818.
7. Buccolerio R. Futerman A. H. (2003) The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol. Res. 47, 409 419.
8. Buntinx M., Vanderlocht J., Hellings N., Vandenabeele F., Lambrichts I., Raus J., Ameloot M., Stinissen P. Steels P. (2003) Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J. Neurocytol. 32, 25 38.
9. Chalfant C. E. Spiegel S. (2005) Sphingosine-1-phosphate and ceramide-1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118, 4605 4612.
10. Chalfant C. E., Rathman K., Pinkerman R. L., Wood R. E., Obeid L. M., Ogretmen B. Hannun Y. A. (2002) De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587 12595.
11. Chen S., Lee J.-M., Zeng C., Chen H., Hsu C. Y. Xu J. (2006) Amyloid beta-preptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J. Neurochem. 97, 631 640.
12. Cheng H., Guan S. Han X. (2006) Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy. J. Neurochem. 97, 1288 1300.
13. Cho S. Dawson G. (2000) Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells. J. Neurochem. 74, 1478 1488.
14. Dawkins J. L., Hulme D. J., Brahmbhatt S. B., Auer-Grumg M. Nicholson G. A. (2001) Mutations in serine:palmitoyltransferase result in inherited peripheral neeuropathy. Nature (Genet.) 27, 309 312.
15. Dawson G. (2000) Mechanisms of apoptosis in embryonic cortical neurons (E6 and E7) in culture involve lipid signaling, protein phosphorylation and caspase activation. Int. J. Dev. Neurosci. 18, 247 257.
16. Dawson G., Kruske A. W. Scanu A. (1976) Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyper-lipidemias. J. Biol. Chem. 17, 125 131.
17. Dawson G., Hancock L. W. Vartanian T. (1986) Regulation of GM2 ganglioside metabolism in cultured cells. Chem. Phys. Lipids, 42, 105 116.
18. Dawson G., Dawson S. A. Post G. R. (1993) Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG). J.Neurosci. Res. 34, 324 330.
19. Dawson G., Moskal J. R. Dawson S. A. (2004) Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U373 MG affects glycoconjugate expression and enhances cell death. J. Neurochem. 89, 1436 1447.
20. Dupree J. L. Popko B. (1999) Genetic dissection of myelin galactolipid function. J. Neurocytol. 28, 271 279.
21. El Bawab S., Usta J., Roddy P., Szulc Z. M., Bielawska A. Hannun Y. A. (2002) Substrate specificity of rat brain ceramidase. J. Lipid Res. 43, 141 148.
22. Furukawa K., Takamiya K. Furakawa K. (2002) Beta1,4-N-acetyltransferase- GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides. Biochim. Biophys. Acta 1573, 356 362.
23. Futerman A. H. Van Meer G. (2004) The cell biology of lysosomal storage disorders. Nat. Rev. 5, 554 565.
24. Giudici M. L., Vos J. P., Marchesini S., Van Golde L. M. Lopes-Cardozo M. (1992) Uptake and metabolism of fluorescent ceramide analogs by rat oligodendrocytes in culture. FEBS Lett. 314, 471 476.
25. Goswami R. Dawson G. (2000) Does ceramide play a role in neural cell apoptosis. J. Neurosci. Res. 60, 141 149.
26. Goswami R., Kilkus J., Dawson S. A. Dawson G. (1999) Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli. J. Neurosci. Res. 57, 884 893.
27. Goswami R., Ahmed M., Kilkus T., Dawson S. A. Dawson G. (2005a) Differential regulation of ceramide in lipid-rich microdomains (Rafts): antagonistic role of palmotoyl:protein sthioesterase and neutral sphingomyelinase 2, J. Neurosci. Res. 81, 208 217.
28. Goswami R., Singh D., Phillips G., Kilkus J. Dawson G. (2005b) Ceramide regulation of the tumor suppressor phosphatase PTEN in Rafts isolated from neurotumor cell lines. J. Neurosci. Res. 81, 541 550.
29. Gulbins E. Kolesnick R. (2002) Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell. Biochem. 36, 229 244.
30. Han X., Holtzman D., McKeel D. W. Jr., Kelley J. Morris J. C. (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82, 809 818.
31. Han X. Gross R. W. (2005a) Shotgun lipidomics: electrospray ionization mass spectroscopic analysis and quantitation of the cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24, 367 412.
32. Han X. Gross R. W. (2005b) Shotgun lipidomics: multi-dimensional mass spectrometric analysis of cellular lipidomes. Expert Rev. Proteomics 2, 253 264.
33. Han X., Yang K., Yang J., Fikes K. N., Cheng H. Gross R. W. (2006) Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids. J. Am. Soc. Mass Spectrom. 17, 264 274.
34. Haughey N. J., Cutler R. G., Tamara A., McArthur J. C., Vagras D. L., Pardo C. A., Turchan J., Nath A. Mattson M. P. (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann. Neurol. 55, 257 267.
35. Huitema K., van den Dikkenberg J., Brouwers J. F. H. M. Holthuis J. C. M. (2004) Identification of a family of animal sphingomyelin synthases. EMBO J. 23, 33 44.
36. Irie F. Hirabayashi Y. (1999) Ceramide prevents motoneuronal cell death through inhibition of oxidative signal. Neurosci. Res. 35, 135 144.
37. Jennemann R., Sandhoff R., Wang S. et al. (2005) Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc. Natl Acad. Sci. USA 102, 12459 12464.
38. Jeyakumar M., Dwek R., Butters T. D. Platt F. M. (2005) Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. (Neurosci.) 6, 1 12.
39. Karakashian A. A., Giltiay N. V., Smith G. M. Nikolova-Karakashian M. N. (2004) Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation. FASEB J. 18, 968 970.
40. Kihara H., Tsay K. K. Fluharty A. L. (1983) Effect of HEPES on the fibroblast cerebroside sulfate loading test. Biochem. Med. 29, 278 284.
41. Kilkus J., Goswami R., Testai F. D. Dawson G. (2003) Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell lines. J. Neurosci. Res. 72, 65 75.
42. Kolesnick R. Hannun Y. A. (1999) Ceramide and apoptosis. Trends Biochem. Sci. 24, 224 225.
43. Krueger R. C., Santore M. T., Dawson G. Schwartz N. B. (2001) Increased extracellular magnesium modulates proliferation in fetal neural cells in culture. Dev. Brain Res. 127, 99 109.
44. Kuemmel T. A., Schroeder R. Stoffel W. (1997) Light and electron microscopic analysis of the central and peripheral nervous systems of acid sphingomyelinase-deficient mice resulting from gene targeting. J. Neuropathol. Exp. Neurol. 56, 171 179.
45. Lee J. T., Xu J. Hsu C. Y. (2004) Amyloid beta-peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123 131.
46. Liu Y. Y., Han T. Y., Giukiano A. E. Cabot M. C. (2001) Glucosyltransferase inhibitors as anti-cancer drugs. FASEB J. 15, 785 791.
47. Mangoura D., Sakellaridis N. Vernadakis A. (1988) A GABAergic neurons in cultures derived from three-, six-, or eight- day old chick embryos: a biochemical and immunohistochemical study. Dev. Brain Res. 40, 25 35.
48. Marchesini N., Luberto C. Hannun Y. A. (2003) Biochemical properties of mammalian neutral sphingomyelinase2 and its role in sphingolipid metabolism. J. Biol. Chem. 278, 13775 13783.
49. Marks J. D., Bindokas V. P. Zhang X. M. (2000) Maturation of vulnerability to excitotoxicity: intracellular mechanisms in cultured postnatal hippocampal neurons. Brain Res. Dev. Brain Res. 124, 101 116.
50. McCarthy K. de Vellis J. (1980) Preparation of separate astroglial and Oligodendrogial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890 902.
51. Pacuszka T. Fishman P. H. (1991) Metabolism of cholesterol, phosphatidylethanolamine and stearylamine analogues of GM1 ganglioside by rat glioma C6 cells. Biochim. Biophys. Acta 1083, 153 160.
52. Post G. R. Dawson G. (1992) Characterization of a cell line derived from a human oligodendroglioma. Mol. Chem. Neuropathol. 16, 308 317.
53. Puranam K., Qian W. H., Nikbakht K., Venable M., Obeid L., Hannun Y. Boustany R. M. (1997) Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28, 37 41.
54. Riboni L., Viani P., Bassi R., Stabilini A. Tettamanti G. (2000) Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary cell culture. Glia 32, 137 145.
55. Rohrbough J., Rushton E., Palanker L., Woodruff E., Matthies H. J., Acharya U., Acharya J. K. Broadie K. (2004) Ceramidase regulates synaptic vesicle exocytosis and trafficking. J. Neurosci. 24, 7789 7803.
56. Sawai H., Domae N. Okazaki T. (2005) Current status and perspectives in ceramide-targeting in molecular medicine. Curr. Pharm. Des. 11, 1 9.
57. Scurlock B. Dawson G. (1999) Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J. Neurosci. Res. 55, 514 522.
58. Shao Z. H., Chang W. T., Chan K. C. et al. (2007) Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling. Am. J. Physiol. Heart Circ. Physiol. 292, 1995 2003.
59. Sharma D. K., Brown J., Choudhury A., Peterson T. E., Holicky E., Marks D. L., Simari R., Parton R. G. Pagano R. E. (2004) Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol. Biol. Cell 15, 3114 3122.
60. Simpson M., Cross H., Platt F. M. Crosby A. H. (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nature (Genet.) 36, 1225 1229.
61. Singh R. D., Puri V., Valiyaveetil J. T., Marks D. L., Bittman R. Pagano R. E. (2003) Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell 14, 3254 3265.
62. Siskind L. J., Kolesnick R. J. Colombini M. (2006) ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6, 118 125.
63. Stoffel W., Jenke B., Block B., Zumbansen M. Koebke J. (2005) Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl Acad. Sci. USA 102, 4554 4559.
64. Taguchi Y., Kondo T., Watanabe M., Miyaji M., Umehara H., Kozutsumi Y. Okazaki T. (2004) Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3-kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase and glucosylceramide synthase. Blood 104, 3285 3293.
65. Testai F. D., Landek M. A. Dawson G. (2004a) Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J. Neurosci. Res. 75, 66 74.
66. Testai F. D., Landek M. A., Goswami R., Ahmed M. Dawson G. (2004b) Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling. J. Neurochem. 8, 636 644.
67. Tettamanti G. (2004) ganglioside/glycosphingolipid turnover: new concepts. Glycoconj. J. 20, 301 317.
68. Tomas M., Duran J. M., lazaro-Dieguez F., Babia T., Renau-Piqueras J. Egea G. (2004) Fluorescent analogs of plasma membrane sphingolipids are sorted to different intracellular compartments in astrocytes. FEBS Lett. 563, 59 65.
69. Tuson M., Marfany G. Gonzalez-Duarte R. (2004) Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26). Am. J. Hum. Genet. 74, 128 138.
70. Unschuld P. G., Daschel J., Darios F. Lucking C. B. (2006) Parkin modulates gene expression in control and ceramide-treated PC12 cells. Mol. Biol. Rep. 33, 13 32.
71. Venkataraman K. Futerman A. H. (2000) ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol. 10, 408 412.
72. Verheij M., Bose R. Grant S. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75 79.
73. deVries H., Schrage C., Hoekstra K., Kok J. W., van der Haar M. E., Kalicharan D., Liem R. S., Copray J. C. Hoekstra D. (1993) Outstations of the Golgi are present in processes of cultured rat oligodendrocytes. J. Neurosci. Res. 36, 336 343.
74. Wanner R., Peiser M. Wittig B. (2004) Keratinocytes rapidly readjust ceramide-sphingomyelin homeostasis and contain a phosphatidylcholine- sphingomyelin transacylase. J. Invest. Dermatol. 122, 773 782.
75. Weisner D. A. Dawson G. (1996) Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66, 1418 1425.
76. Wiesner D. A., Kilkus J. P., Gottschalk A. R., Quintans J. Dawson G. (1997) Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J. Biol. Chem. 272, 9868 9876.
77. Yamaoka S. T., Miyaji M., Kitano Y., Umehara H. Okazaki T. (2004) Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J. Biol. Chem. 279, 18688 18693.
78. Yu Z. F., Nikolova-Karakashian M., Zhou D., Cheng G., Schuchman E. H. Mattson M. P. (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J. Mol. Neurosci. 15, 85 97.